Congress Day 4. Join us for the final CME session for discussion of PCSK9 lowering and LDL-C reduction.
Lowering circulating PCSK9 to reduce LDL cholesterol: Current approaches
Chairs: Alberico L. Catapano, Italy & Lale Tokgözoglu, Turkey
- The biology of PCSK9, Bertrand Cariou, Nantes, France
- Monoclonal antibody approaches targeting circulating PCSK9, Ulf Landmesser, Berlin, Germany
- siRNA based approaches targeting hepatic synthesis of PCSK9, Kausik Ray, London, UK
- Panel discussion, with live Q&A
Plan your programme in the congress app or use the full interactive Programme web app if you are on a computer. The mobile and web apps sync, if you are logged in, so you can keep track of your programme at any time.